Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
Introduction to Lophophora
williamsii (peyote)
Peyote
is a small, psychoactive cactus that grows in Mexico and small part of Texas, in
the USA. It grows in the Chihuahuan...
In the 2020 election, we have witnessed major drug policy reform happen in states like Oregon which has voted in a psilocybin therapy model and broad drug decriminalization. What should Californian constituents consider for the future of psychedelic legislation? Ariel Clark argues that psychedelic legislation should begin with decriminalizing all drugs.
Martin R. Steele, Chief Executive Officer of Reasons for Hope, writes on behalf of the Veteran Mental Health Leadership coalition to the House Veterans' Affairs Committee to recommend increased funding for psychedelic-assisted therapy for Veteran suicide prevention. They recommend four actions to be taken by the committee.
In December 2017, indigenous Brazilian ayahuasqueiros from the north-western State of Acre came together at the Yubaka Hayrá—the inaugural Indigenous Ayahuasca Conference, in the...
RESOLUTION NO. NS-29,623
A RESOLUTION OF THE CITY COUNCIL OF THE CITY OF SANTA CRUZ DECLARING THAT THE INVESTIGATION AND ARREST OF INDIVIDUALS TWENTY-ONE (21)...
For four years, Soul Quest and their lawyers petitioned for Religious Freedom Restoration Exemption against the DEA for interfering with ayahuasca ceremonies. On April 16, 2021, the DEA’s Diversion Control Division denied their petition to carry on its ayahuasca ceremonies legally. This article describes key takeaways on the DEA’s denial, the impacts for the larger ayahuasca community, and the road ahead.
The War on Drugs in Latin America and the Caribbean has negatively impacted the Indigenous peoples of the region. This US-driven approach to the illegal drug market is based on a militarized strategy that represses users, mass incarcerates the poorest populations, and is used to advance elite interests and global capitalism.
Cross Movement Learning
Social change movements
can often learn from each other. This article explores ideas and lessons the
movement to expand end of life liberty (also...
María Sabina, the curandera who revealed the psychedelic mushroom to the Western world, ultimately died in poverty.
Venture capital is betting big on the potential...
This article takes a look at the controversies surrounding patenting psychedelics by analyzing the history of patents as a whole and applying this to the quickly emerging decriminalization and legalization of psychedelics. Chris Byrnes & Graham Pechenik delve into current policies taking place and describe the potential pros and evident cons of patents in psychedelics.